Constellation Pharmaceuticals Announces Second-Quarter and Six-Month 2019 Financial Results

    NEXT STORY
    CytomX Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update
    PREV STORY
    Verrica Pharmaceuticals Reports Second Quarter 2019 Financial Results
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    OncXerna Therapeutics to Participate at the Upcoming Investor Conferences

    author_avatar
    NASDAQ Market News

    Rhythm Pharmaceuticals Announces Appointment of David Meeker, M.D., as Chief Executive Officer

    author_avatar
    NASDAQ Market News

    Stemline Therapeutics Clears First Cohort of Patients in Ongoing SL-801 Phase 1 Trial

    NEW YORK, May 03, 2016 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today ...

    author_avatar
    NASDAQ Market News